Day: April 11, 2025

SINGAPORE, April 11, 2025 (GLOBE NEWSWIRE) — Cuprina Holdings (Cayman) Limited (Nasdaq: CUPR) (“CUPR” or “the Company”), a biomedical and biotechnology company dedicated to the development and commercialization of products for the management of chronic wounds as well as cosmeceuticals for the health and beauty sector, today announced the closing of its previously announced initial public offering of an aggregate 3,000,000 Class A Ordinary Shares (“the Offering”) at a price of $4.00 per share (“the Offering Price”) to the public, for a total of $12.0 million of gross proceeds to the Company, before deducting underwriting discounts and offering expenses. The Company intends to use net proceeds from the Offering for expansion into new markets, R&D activities to expand its product portfolio, research and development activities,...

Reference is made to the Extraordinary General Meeting in IDEX Biometrics ASA (“IDEX” or the “Company”) on 11 April 2025, where all proposed resolutions were approved. Key information relating to the approved share consolidation:  Date on which the terms and conditions of the share consolidation was made public: 11 April 2025; Share consolidation ratio: 100 old shares give 1 new share; Last day including right: 10 June 2025; Ex-date: 11 June 2025; Record date: 12 June 2025; and Date of approval: 11 April 2025 In connection with the share consolidation, the Company’s shares will be transferred to a new ISIN. Please find below the following key information for the change of ISIN: Issuer: IDEX Biometrics ASA Old ISIN: NO0013107490 New ISIN: NO0013536078 Date of ISIN change: 11 June 2025. For further information...

CHENNAI, India, April 11, 2025 (GLOBE NEWSWIRE) — Sify Technologies Limited (NASDAQ: SIFY), India’s leading Digital ICT solutions provider with global service capabilities spanning Data Center, Cloud, Networks, Security and Digital services, today announced that it will report its unaudited IFRS financial results for the full year ended March 31, 2025 on Friday, April 18, 2025. The following Monday, April 21, 2025, Sify will host a conference call at 8:30 AM ET with Mr. Raju Vegesna, Chairman of the Board and Mr. M P Vijay Kumar, Executive Director and Group CFO. Interested parties may participate by dialling +1-888-506-0062 (Toll Free in the U.S. or Canada) or +1-973-528-0011 (International) with access code: 680924, which will also be simultaneously broadcast live over the Internet at www.sifytechnologies.com/investors or https://www.webcaster4.com/Webcast/Page/2184/52330. Please...

Strategic Divestiture Continues Focus on Core Forever 8 Business’ Long-Term Growth Easton, PA, April 11, 2025 (GLOBE NEWSWIRE) — Eightco Holdings Inc. (NASDAQ: OCTO) (the “Company” or “Eightco”) today announced that it has completed the sale of its subsidiary, Ferguson Containers, Inc., to Reichard Corrugated Products, LLC, an entity controlled by the existing management of Ferguson Containers. “We are pleased to announce the sale of Ferguson Containers. This planned divestiture is a milestone that will allow both companies to better position themselves for long-term success and aligns with our focus on our core business,” said Paul Vassilakos, CEO of Eightco and President of Forever 8 Fund, LLC (“Forever 8”), the Company’s remaining subsidiary. “We are grateful for the commitment and value Ferguson Containers has provided us....

PALO ALTO, Calif., April 11, 2025 (GLOBE NEWSWIRE) — Scilex Holding Company (Nasdaq: SCLX, “Scilex” or “Company”), an innovative revenue-generating company focused on acquiring, developing and commercializing non-opioid pain management products for the treatment of acute and chronic pain and, following the formation of its proposed joint venture with IPMC Company, neurodegenerative and cardiometabolic disease, today announced that it will effect a reverse stock split of its outstanding shares of common stock at a ratio of 1-for-35, to be effective as of 12:01 a.m. Eastern Time on April 15, 2025. Scilex’s common stock will begin trading on a reverse stock split-adjusted basis at the opening of the market on April 15, 2025. Following the reverse stock split, Scilex’s common stock will continue to trade on The Nasdaq Capital Market...

GLYFADA, Greece, April 11, 2025 (GLOBE NEWSWIRE) — United Maritime Corporation (the “Company” or “United”) (NASDAQ: USEA) announced today that its Annual Report on Form 20-F for the fiscal year ended December 31, 2024 (the “Annual Report”) has been filed with U.S. Securities and Exchange Commission. The Annual Report may also be accessed through United’s website, www.unitedmaritime.gr, at the “Investors” section under “Annual Reports”. About United Maritime CorporationUnited Maritime Corporation is an international shipping company specializing in worldwide seaborne transportation services. The Company operates a fleet of eight dry bulk vessels, comprising three Capesize, two Kamsarmax and three Panamax vessels, with an aggregate cargo carrying capacity of 922,072 dwt. Upon the completion of the sale of the M/V Gloriuship, the...

Bowie, MD., April 11, 2025 (GLOBE NEWSWIRE) — Blink Charging Co. (Nasdaq: BLNK) (“Blink” or the “Company”), a leading global owner, operator, provider, and manufacturer of electric vehicle (EV) charging equipment and services, today announced that it received a letter from The Nasdaq Stock Market LLC (“Nasdaq”), dated April 10, 2025, informing the Company that it has regained compliance with Nasdaq’s periodic filing requirement under Nasdaq Listing Rule 5250(c)(1). On April 9, 2025, Blink filed its Form 10-K for the year ended December 31, 2024, with no change to the 2024 financial results as reported in the Company’s fourth quarter and full year 2024 press release, earnings call, and investor deck issued on March 13, 2025. There were no restatements of previously filed financial statements.  ## About Blink Charging Blink Charging...

ROBESONIA, Pa., April 11, 2025 (GLOBE NEWSWIRE) — Blaqclouds, Inc. (OTC: BCDS) is proud to announce the official launch of its ZEUSxPay-powered bulk email marketing campaign, aimed at driving awareness and adoption of its growing “With Crypto” ecosystem, which includes live platforms like ShopwithCrypto.io, DinewithCrypto.io, and soon-to-launch verticals DrivewithCrypto.io and StaywithCrypto.io. This campaign marks a strategic push to onboard token projects and expand real-world utility for digital assets through the Blaqclouds proprietary payment infrastructure—ZEUSxPay. ZEUSxPay: The Exclusive Engine Behind “With Crypto” ZEUSxPay, a Layer 2 decentralized payment solution built on the high-speed Layer 1 ZEUS Blockchain, is the exclusive payment gateway across all “With Crypto” brand platforms. Supporting over 300 tokens and coins...

DELRAY BEACH, Fla., April 11, 2025 (GLOBE NEWSWIRE) — In celebration of National Pet Day, PetMed Express, Inc. (NASDAQ: PETS)—the original consumer pet healthcare company serving dogs, cats, and horses for nearly 30 years—will ring the Nasdaq Opening Bell this Friday, April 11, 2025. This momentous occasion honors the powerful bond between people and their pets and will feature adoptable rescue dogs from Bidawee, one of the nation’s oldest no-kill animal welfare organizations. It’s a tribute to the joy and unconditional love pets bring into our lives–and a reminder of how many still await families of their own. “Our pets are more than just animals; they are family,” said Sandra Campos, President & CEO of PetMeds and PetCareRx®. “As a pet parent to three rescue dogs, nine rescue horses, and one outspoken senior...

ATLANTA, April 11, 2025 (GLOBE NEWSWIRE) — Dogwood Therapeutics, Inc. (Nasdaq: DWTX) (the “Company”), a development-stage biopharmaceutical company focused on developing new medicines to treat pain and fatigue-related disorders, today announced that it has received written confirmation from Nasdaq that it has regained compliance with Nasdaq Listing Rule 5550(b)(1), which requires minimum stockholders’ equity of $2.5 million. DWTX Chairman and CEO Greg Duncan stated, “We are pleased that the Company successfully implemented a plan to regain compliance and meet the equity requirement and is continuing to execute that plan going forward.” He continued, “The Company has a strong cash position of $17.5 million as of the end of Q1, and we are dosing patients in our Halneuron® Phase 2b Chemotherapy Induced Neuropathic Pain Trial to support...